title: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.
authors.affiliation: Kentucky Clinic, University of Kentucky, Lexington, KY, USA.
authors.forename: Hatim
authors.initials: H
authors.lastname: Omar
authors.forename: Sari
authors.initials: S
authors.lastname: Kives
mesh_terms: D000293:Adolescent; D015519:Bone Density / Q000187:drug effects*; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects*; D010024:Osteoporosis / Q000139:chemically induced
chemical_list: D003280:Contraceptives, Oral, Synthetic; D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate